-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-3-version-1.xlsx
February 01, 2020 - Inclusion Criteria Sample Size Age (mean, years) Female % Healthcare Worker Type/Role Definition of HCW Infection … Proportion (%) of HCWs With Infections Results: Mask Use Versus Nonuse Results: Comparison of Mask Types … Study Limitations
Alradaddi B et al 2016 Risk factors for Middle East Respiratory Syndrome coronavirus infection … eye protection
Not reported Potential recall bias
Caputo K et al 2006 Intubation of SARS patients: infection … 2020 Association between 2019-nCoV transmission and N95 respirator use 10-Apr-20 Journal of Hospital Infection
-
effectivehealthcare.ahrq.gov/products/prevent-hai/protocol
-
effectivehealthcare.ahrq.gov/products/ems-911-workforce-infection-control/report
-
effectivehealthcare.ahrq.gov/sites/default/files/Masks-appendix-table-b-3-surveillance-report.xlsx
February 01, 2020 - Sample Size Age (mean, years) Female % Healthcare Worker Type/Role Definition of Healthcare Worker Infection … Proportion (%) of Healthcare Workers With Infections Results: Mask Use Versus Nonuse Results: Comparison … Study Limitations
Alradaddi B et al 2016 Risk factors for Middle East Respiratory Syndrome coronavirus infection … eye protection
Not reported Potential recall bias
Caputo K et al 2006 Intubation of SARS patients: infection … 2020 Association between 2019-nCoV transmission and N95 respirator use 10-Apr-20 Journal of Hospital Infection
-
effectivehealthcare.ahrq.gov/sites/default/files/masks-appendix-table-b-3-version-2.xlsx
February 01, 2020 - Sample Size Age (mean, years) Female % Healthcare Worker Type/Role Definition of Healthcare Worker Infection … Proportion (%) of Healthcare Workers With Infections Results: Mask Use Versus Nonuse Results: Comparison … Study Limitations
Alradaddi B et al 2016 Risk factors for Middle East Respiratory Syndrome coronavirus infection … eye protection
Not reported Potential recall bias
Caputo K et al 2006 Intubation of SARS patients: infection … 2020 Association between 2019-nCoV transmission and N95 respirator use 10-Apr-20 Journal of Hospital Infection
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Comparative Effectiveness Review
Surveillance Program
CER #76: Treatment for Hepatitis C Virus Infection … , and Sofosbuvir (Sovaldi) for treatment of chronic hepatitis C virus infection. … Treatment for
Hepatitis C Virus Infection in Adults. CER # 76. … Clinical Microbiology and Infection 6.! JAMA Internal Medicine
7.! … Hepatic immune regulation and its involvement in viral hepatitis
infection.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
December 01, 2015 - Comparative Effectiveness Review
Surveillance Program
CER #76: Treatment for Hepatitis C Virus Infection … , and Sofosbuvir (Sovaldi) for treatment of chronic hepatitis C virus infection. … Treatment for
Hepatitis C Virus Infection in Adults. CER # 76. … Clinical Microbiology and Infection 6.! JAMA Internal Medicine
7.! … Hepatic immune regulation and its involvement in viral hepatitis
infection.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
October 26, 2012 - Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled
Trial. … VRE Infection or Colonization /
Hospital-Acquired MRSA Infection or Colonization). … NCT01245829. 2011; Not yet recruiting (Cross Infection / Infection Control). … Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With
Moderate Clostridium Difficile Infections … difficile re-infection?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - A new meta-analysis of 6
RCTs of tocilzumab + MTX
vs. placebo7 showed increased
risk of infection, … Initiation of tumor necrosis factor-alpha antagonists
and the risk of hospitalization for infection … The influence of systemic glucocorticoid therapy
upon the risk of non-serious infection in older patients … The association between systemic glucocorticoid therapy
and the risk of infection in patients with … Tumor necrosis factor therapy and the risk of serious
infection and malignancy in patients with early
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - A new meta-analysis of 6
RCTs of tocilzumab + MTX
vs. placebo7 showed increased
risk of infection, … Initiation of tumor necrosis factor-alpha antagonists
and the risk of hospitalization for infection … The influence of systemic glucocorticoid therapy
upon the risk of non-serious infection in older patients … The association between systemic glucocorticoid therapy
and the risk of infection in patients with … Tumor necrosis factor therapy and the risk of serious
infection and malignancy in patients with early
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/environmental-monitoring-in-healthcare-to-ensure-adequacy-of-housekeeping-cleaning-and-reduce-the-spread-of-hospital-acquired-infections-hais
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
September 13, 2011 - Background and Objectives for the Systematic Review
Hepatitis C virus (HCV) infection is the most … Boceprevir for previously treated chronic HCV
genotype 1 infection. … Boceprevir for untreated chronic HCV genotype 1
infection. … Screening for hepatitis C virus infection: a review of the
evidence for the U.S. … Outcomes of treatment for hepatitis C virus infection
by primary care providers.
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-evidence-summary.pdf
March 01, 2021 - with dinoprostone and maternal infection, birth trauma or
shoulder dystocia with single-balloon catheters … The incidence of meconium
aspiration syndrome, shoulder dystocia, and uterine infection, primarily with … inpatient
Infection
Low-strength
evidence of little or
no difference
2 RCTs
(n=1,120)
4% vs … inpatient
Uterine
Infection
Low-strength
evidence of little or
no difference
2 RCTs
(n=259 … placebo
Uterine
Infection
Low-strength
evidence of a small,
but nonsignificant,
difference
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-hospitalizations_research.pdf
October 01, 2008 - use of RA-
related medications (i.e. immunosuppressives) may affect the clinical manifestations of infection … Rates of serious infection,
including site-specific and bacterial intracellular
infection, in rheumatoid … Risk of serious bacterial infections
among rheumatoid arthritis patients exposed to
tumor necrosis … Veteran's affairs
hospital discharge databases coded serious
bacterial infections accurately. … Confirmation of
administrative claims-identified opportunistic
infections and other serious potential
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
July 19, 2013 - setting, it accounts for up to 25 percent of all infections and for more than 50
percent of the antibiotics … Cases of
infections caused by Gram-positive cocci, including Staphylococcus aureus, are becoming more … The review by Franzetti and colleagues25 (undertaken on behalf
of the Italian Study Group on Serious Infections … Inadequate antimicrobial treatment of infections: a
risk factor for hospital mortality among critically … vancomycin
and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract
infections
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
October 05, 2012 - key questions and PICOTS to generate an analytic
framework for PCT as a diagnostic indicator for infection … Change sentence to, “In 2005 to 2006, 54% of ambulatory visits for
an acute respiratory tract infection … To
clarify my point, imagine that none of the study subjects
actually has bacterial infection (admittedly … The idea that antibiotic use was inappropriate (no infection) in these
studies was reduced as much as … In fact, if the patients met
entry criteria, even in the absence of infection, ABT therapy is still
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
March 09, 2010 - Adalimumab Humira TNF inhibitor;
biologic Yes Infections; cancer
Anakinra Kineret
IL-1 receptor … No Infections; cancer
IVIG
Baygam
Carimune NF
Flebogamma 5% DIF
Gammar P
Gamunex 10%
Gammagard … failure; Venous
thrombosis; aseptic
meningitis
Rilonacept Arcalyst IL-1 blocker;
biologic No Infection … syndrome
Tacrolimus
(FK506) Prograf
Reduces T-cell
and IL-2 activity;
nonbiologic
No Cancer; infection … Specifically, we will examine mortality, malignancy, serious infection,
hepatitis, bone marrow suppression
-
effectivehealthcare.ahrq.gov/products/ems-911-workforce-infection-control/protocol
-
effectivehealthcare.ahrq.gov/products/c-difficile-future/research
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - • The inclusion of the safety outcomes of impaired renal function, urinary tract infections,
genital … , genital mycotic infections, volume depletion, and fractures are potential risks of SGLT-2 inhibitors … , impaired renal function,
genital mycotic infections, fracture, and volume depletion? … , impaired
renal function, genital mycotic infections, fracture, and volume depletion? … §
§ Genital mycotic infections§
§ Volume depletion§
KQ4 will include studies
considering any